e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is science enough to tackle the epidemic?
Migliori G. B., Loddenkemper R., Blasi F., Raviglione M. C.
Source:
Eur Respir J 2007; 29: 423-427
Journal Issue:
March
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Migliori G. B., Loddenkemper R., Blasi F., Raviglione M. C.. 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is science enough to tackle the epidemic?. Eur Respir J 2007; 29: 423-427
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Managing an extensively drug-resistant tuberculosis outbreak: the public health face of the medal
Source: Eur Respir J 2015; 45: 292-294
Year: 2015
Multidrug-resistant tuberculosis around the world: what progress has been made?
Source: Eur Respir J 2015; 45: 150-160
Year: 2015
Escaping the Plato's cave of latent tuberculosis testing: a path for developers of predictive tests for risk of tuberculosis
Source: Eur Respir J, 52 (4) 1801616; 10.1183/13993003.01616-2018
Year: 2018
Towards the elimination of tuberculosis: challenges ahead from a European perspective
Source: Annual Congress 2012 - Joint session with WHO and ECDC "Towards elimination of tuberculosis"
Year: 2012
TB "cross-border" - a new challenge in tuberculosis management
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020
The global response to rifampicin-resistant tuberculosis: Current situation and recent trends
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
Managing difficult TB cases: experiences from the ERS/WHO TB Consilium and other country-specific Consilia
Source: International Congress 2017 – In the frontline of the fight against tuberculosis
Year: 2017
Childhood tuberculosis: a concern of the modern world
Source: Eur Respir Rev 2014; 23: 278-291
Year: 2014
Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis
Source: ERJ Open Res, 6 (4) 00562-2020; 10.1183/23120541.00562-2020
Year: 2020
The top of the iceberg - Extensively drug resistant tuberculosis (XDR-TB) in 2010
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Childhood tuberculosis: progress requires an advocacy strategy now
Source: Eur Respir J 2012; 40: 294-297
Year: 2012
Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Treatment of multidrug-resistant tuberculosis in Uzbekistan from 2012 to 2018: does practice follow policy?
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021
The particularities of new cases of tuberculosis at homeless people
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Tuberculosis elimination, patients' lives and rational use of new drugs: revisited
Source: Eur Respir J 2016; 47: 664-667
Year: 2016
Novel drugs against tuberculosis: a clinician's perspective
Source: Eur Respir J 2015; 45: 1119-1131
Year: 2015
Tuberculosis elimination in Oman: winning the war on the disease
Source: ERJ Open Res, 4 (4) 00121-2018; 10.1183/23120541.00121-2018
Year: 2018
Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement
Source: Eur Respir J 2012; 40: 1081-1090
Year: 2012
DOTS strategy - key for the progress in the control of TB; five years of experience in Iasi County
Source: Eur Respir J 2004; 24: Suppl. 48, 724s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept